Renal Insufficiency, Chronic: all 3,224 studies
Page 33 of 33. Open to participants first (706), then studies with results posted, then the rest; newest registration first within each.
- An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)CompletedNCT00124098Phase 3
- Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary HyperparathyroidismCompletedNCT00123461Phase 4
- Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney DiseaseCompletedNCT00121602Phase 3
- Treatment for Subjects With Chronic Kidney Disease Receiving HaemodialysisCompletedNCT00116701Phase 3
- Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving DialysisCompletedNCT00112008Phase 3
- Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving HemodialysisCompletedNCT00111995Phase 4
- Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving DialysisCompletedNCT00111098Phase 3
- Safety of Single Doses of Peginesatide in Patients With Chronic Kidney DiseaseTerminatedNCT00109291Phase 2
- Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy VolunteersCompletedNCT00097747Phase 1
- A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)CompletedNCT00097617
- Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving DialysisCompletedNCT00096915Phase 3
- Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving DialysisCompletedNCT00094484Phase 3
- Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney DiseaseCompletedNCT00093977Phase 3
- Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal DialysisCompletedNCT00091975Phase 3
- Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on HemodialysisCompletedNCT00091481Phase 4
- Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring HemodialysisTerminatedNCT00086164Phase 1/2
- A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on DialysisCompletedNCT00081471Phase 3
- Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of CalciumCompletedNCT00073710Phase 4
- Role of Chronic Kidney Disease in Cardiovascular DiseaseWithdrawnNCT00069810
- Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on HemodialysisTerminatedNCT00062699Phase 4
- Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)CompletedNCT00048516Phase 3
- Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)CompletedNCT00048451Phase 3
- Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)CompletedNCT00048438Phase 3
- The Jackson Heart Study of Cardiovascular Disease Among African AmericansActive, not recruitingNCT00005485